Cosentyx snrdy 300MG dose-2PENML
Ended Awarded Last action
- Contract number
- SPE2DR26FRB4R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $104,658
Award facts
- Contract value 100% obligated
- $104,657.95 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on April 13, 2026, with a ceiling value of $104,657.95 for COSENTYX (secukinumab) 300 mg dose, 2 pens per milliliter.
The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2026. Place of performance is Conshohocken, PA. Ultimate completion date is April 14, 2026. The order is priced on a firm fixed-price basis with no set-aside.
Quick answers
Who was awarded contract SPE2DR26FRB4R?
SPE2DR26FRB4R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 13, 2026.
How much is contract SPE2DR26FRB4R worth?
The government has obligated $104,658 on SPE2DR26FRB4R.
Is contract SPE2DR26FRB4R an order under another contract?
Yes. SPE2DR26FRB4R is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FRB4R competed?
The extent of competition for SPE2DR26FRB4R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award